20 06, 17
If you are attending the Human Brain Mapping conference in Vancouver, Canada, stop by at our booth (#38) and you'll meet BrainVoyager experts answering your questions! We are thrilled to show you our latest 20.6 BrainVoyager version that supports nonparametric permutation inference, direct NIfTI support from the File menu, and enhanced probability maps to create volume and surface space atlases. You can also see what's coming in our next major release, BrainVoyager 21 focusing on compute server integration, next level visualizations and much more! We also provide information about the upcoming 4.0 release of our real-time fMRI software Turbo-BrainVoyager that will greatly help to improve and customise clinical neurofeedback studies. Furthermore, we also demo the latest version of our TMS Neuronavigator product allowing to save and visualize previously stimulated 6D target points. You can also see some of our upcoming new products in action - besides a new mobile / desktop Brain Viewer application, you can have a Rift preview experience of "Brain Tutor VR" and check out our new augmented reality iOS app "Brain Tutor AR" providing a very entertaining way to learn about the brain!
25 06, 16
f you are attending the HBM conference in Geneva, Switzerland, stop by at our booth (#24) and you'll meet BrainVoyager experts answering your questions! We are thrilled to show you our recently released BrainVoyager 20 that redefines the way in which you manage and analyse your data for reproducible results. Among many other enhancements, the new version also provides boundary-based registration that can be used for precise alignment of functional and anatomical data even in case of sub-millimeter 7T fMRI measurements. We also provide information about the upcoming 4.0 release of our real-time fMRI software Turbo-BrainVoyager that will greatly help to improve and customise clinical neurofeedback studies. Furthermore, we also demo the latest version of our TMS Neuronavigator product allowing to save and visualize previously stimulated 6D target points. You can also see our upcoming new products in action - you can experience brains and fiber tracts in 3D with a Oculus Rift demo and you can draw directly on brain surfaces on our tablet BrainStar software using a pressure-sensitive pencil to demarcate and label (functional) brain regions!
12 12, 15
11 06, 15
f you are attending the HBM conference in Honolulu, Hawaii, stop by at our booth (#116) and you'll meet BrainVoyager experts answering your questions! We are thrilled to show you our upcoming new major release of BrainVoyager that redefines the way in which you manage and analyse your data: Instead of isolated documents, data is stored under experiments, subjects and analysis workflows in a hierarchical manner. Since specified workflows know about the data belonging to an experiment, processing can be performed in the same way for all available subjects of an experiment constituting a powerful batch processing mechanism without the need to write scripts. Furthermore, workflows create detailed reports in HTML and PDF format as a basis for quality assurance and documentation of performed analysis steps. Besides a new data analysis management, BrainVoyager adds many new features and enhancements, including MNI template normalisation, a cover flow like Workspace Panel containing a graphical overview of available (open) documents, a new Zoom View panel allowing detailed inspection of documents and the possibility to edit segmentation VMR documents with full undo/redo functionality. We also show exciting new developments of our real-time fMRI software Turbo-BrainVoyager that greatly help to improve and customise clinical neurofeedback studies. We also demo the latest version of our TMS Neuronavigator product and tell you about other available and upcoming software products.
12 12, 14
Following an invitation of the TEDxAmsterdam organisers, Rainer Goebel gave a TEDx talk in Amsterdam on November 28, 2014. In his 18 minutes talk, Rainer explains how real-time fMRI works and how it enables novel clinical applications that may help patients with psychiatric and neurological diseases.